The global diabetic socks market size was USD 344.80 Million in 2021 and is expected to register a revenue CAGR of 4.8% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of diabetics and related complications such as Diabetic Food Ulcer (DFC) and diabetic neuropathy, growing consumer demand for better & improved accessibility and benefits offered by diabetic socks to patients over regular socks, and introduction of innovative smart sock technology are factors driving market revenue growth.
Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabetic retinopathy is broadly classified into non-proliferative diabetic retinopathy and proliferative retinopathy. Treatment for diabetic retinopathy depends on the stage of the disease and is directed toward slowing down or stopping the progression of the disease. Read more details at: http://www.bigmarketresearch.com/global-diabetic-retinopathy-2015-2019-market
Diabetic macular edema treatment market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 3.65% in the above mentioned forecast period and would likely to reach an estimated value of 63.33 million by 2029 https://www.databridgemarketresearch.com/reports/global-diabetic-macular-edema-treatment-market
Get more information @ http://bit.ly/2kq4uSV Some of the key players in the diabetic retinopathy market include Bayer, Valeant Pharmaceutical, Novartis, F. Hoffmann-La Roche, Alimera Science, Abbott Laboratories, Pfizer, Regeneron Pharmaceutical, and Ampio Pharmaceuticals. Other notable players include Actavis, Boehringer Ingelheim, Kowa group, BCN peptides, ThromboGenics, Bausch & Lomb, iCo Therapeutics, Quark Pharmaceuticals and Vitreoretinal Technologies among others.
Get more information @ http://bit.ly/2kq4uSV North America is predicted to contribute maximum revenue share in access of $4 billion by end of forecast timeframe. Growing access to anti-VEGF items like lucentis, eyelea and avastin along with growing consciousness for early diagnosis to avoid further blindness related with diabetes are the factors predicted to drive the industry demand in the region.
According to the latest research report by IMARC Group, The global vision care market size reached US$ 71.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 93.9 Billion by 2032, exhibiting a growth rate (CAGR) of 3% during 2024-2032. More Info:- https://www.imarcgroup.com/vision-care-market
Global Widefield Imaging Systems Market will exhibit a CAGR of around 7.35% for the forecast period of 2022-2028. Widefield imaging systems are used in diagnosing and detecting uveitis, diabetic retinopathy, retinal vascular tumours among others. Widefield imaging systems offer excellent postoperative documentation of retinal surgery. Widefield imaging systems is an imaging technology that relies on illumination with the resulting image being viewed and observed by an observer through the camera. The widefield imaging systems are rapidly being adopted by hospitals, clinics, and ambulatory surgery centres. Get Full Access of Report @ https://www.databridgemarketresearch.com/reports/global-widefield-imaging-systems-market
According to the latest research report by IMARC Group, The global eye health supplements market is expected to exhibit a growth rate (CAGR) of 6% during 2023-2028. More Info:- https://www.imarcgroup.com/eye-health-supplements-market
Grape Seed Extracts Industry is expected to register 7.5% CAGR between 2021 and 2027, supported by rising importance of grape seed extracts as a functional ingredient that aids in weight loss, cellulite reduction, and improvement of the immune system.The Grape Seed Extracts Market value is expected to cross USD 227 million by 2027, according to a new research report by Global Market Insights Inc. Increasing consumer inclination towards health & wellness coupled with favourable antioxidant, antifungal and anti-inflammatory properties of product will escalate the product demand.
An extensive study of the product application and services conducted by subject matter experts assessing the market will help product owners to make a wise decision.
Looking forward, the ophthalmic lasers market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/ophthalmic-lasers-market
The Global Retinal Disease Therapeutics Market is likely to expand at an impressive rate driven by recent government participation towards the prevention and control of retinal diseases
The rising incidences of colorectal cancer, chronic pain, cardiovascular diseases and diabetic retinopathy and unwanted pregnancies globally are expected to drive the implantable drug delivery devices market.
According to Our Research analysis Ophthalmic Device Market is expected to be US$ 67 Billion by the end of the year 2026. This growth is due to rise in the adoption of digital devices such as laptops, smartphones, tablets, computers, game consoles, television, and e-reader as well as rapid urbanization. Another factor is growing geriatric population globally and a rise in the incidence of chronic eye conditions as a consequence of unhealthy lifestyle results in diabetic retinopathy. Moreover, high stress is also an added reason for the growth in the ophthalmic device market. Follow the Link for More Information: https://www.renub.com/global-ophthalmic-devices-market-nd.php
The prevalence of eye diseases such as glaucoma, cataracts, and so on is increasing significantly worldwide, as a consequence of increasing incidences of chronic disorders such as hypertension and diabetes. Due to changing lifestyle, the number of patients affected with diabetes and hypertension has increased considerably, thereby resulting in growth of ocular hypertension and diabetic retinopathy. The number of patients suffering from ophthalmic disorders is anticipated to increase in coming years and is in turn expected to accelerate the demand for ophthalmic devices.
Vitrectomy serves as major treatment option that has gained popularity since the past few years and also offers retina correction for the entire field of the interior of the eye, which includes the peripheral vision. Moreover, when it comes to defining Vitrectomy, it is a surgical procedure employed to eradicate vitreous gel from the eye. This process is done when there is an occurrence of retinal detachment with vitreous haemorrhage. In addition, this procedure is used for eradication of scar tissue and treatment for small holes or tear in the macula.
According to the latest research report by IMARC Group, The global eye health supplements market size is projected to exhibit a growth rate (CAGR) of 5.4% during 2024-2032. More Info:- https://www.imarcgroup.com/eye-health-supplements-market
According to the latest research report by IMARC Group, The global ophthalmic devices market size reached US$ 27.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 38.5 Billion by 2032, exhibiting a growth rate (CAGR) of 3.7% during 2024-2032. More Info:- https://www.imarcgroup.com/ophthalmic-devices-market
According to Prevent Blindness statistics, the prevalence of diabetic retinopathy in the U.S. is estimated to be 5.3%. VEGF-A antagonist is largely prescribed for the diabetic retinopathy treatment and also for treatment of diabetic macular edema.
Stay up-to-date with latest Insights of Ophthalmic Drugs Market research offered by Allied Market Research. Check how key trends and emerging drivers are shaping this industry growth. Get More Info@ https://www.alliedmarketresearch.com/ophthalmic-drugs-market
The major factors that drive the growth of the global ocular drug delivery technology market are the low bioavailability of drugs in conventional ocular therapies, increase in the incidence of glaucoma & macular degeneration, growing demand for targeted ocular drug delivery techniques, and increase in the number of approvals from government regulations for new ocular drug delivery techniques. Get sample copy of this report: https://goo.gl/S9nZMM
Get sample copy: http://bit.ly/2EXE0jn The major factors that drive the growth of the global ocular drug delivery technology market are the low bioavailability of drugs in conventional ocular therapies, increase in the incidence of glaucoma & macular degeneration, growing demand for targeted ocular drug delivery techniques, an increase in the number of approvals from government regulations for new ocular drug delivery techniques.
Ophthalmology is basically the branch of medical science study of the eye and its various structure, function and treatment, cure and diagnosis of eye diseases and clinical conditions, such as cataract, diabetic retinopathy, age-related macular degeneration, glaucoma and astigmatism. The ophthalmology devices are medical equipment designed for surgery, diagnosis and vision correction.
Global proanthocyanidins market is set to witness a substantial CAGR of 6.25% in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Increasing demand for food products with anti- cancer properties and rising awareness about therapeutic benefits of dietary supplements are the factor for the growth of this market.
The global ophthalmic equipment market size was USD 60.49 Billion in 2021 and is expected to register a revenue CAGR of 5.0% during the forecast period, according to latest analysis by Emergen Research. Rising prevalence of glaucoma, cataracts, and other ocular conditions, increasing need for Research & Development (R&D) due to prevalence of eye-related diseases, need for improved patient outcomes, and use of cutting-edge technologies are major factors driving market revenue growth.
iGATE Research has released a research report on “Global Retinal Surgery Devices Market (By Devices Segment, Application, Geography, Region and Company Profile) – Forecast to 2026” Click here to view the complete report: https://www.igateresearch.com/global-retinal-surgery-devices-market-by-devices-segment-application-geography-region-and-company-profile-forecast-to-2026.html Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com
The global ophthalmic devices market was valued at USD 29,171.5 million in 2014 and is expected to grow at a CAGR of 6.5% from 2014 to 2020, to reach an estimated value of USD 42,685.1 million in 2020.
The Global Ophthalmic sutures market share report provides numbers for applications and regional segments of the industry covering historical as well as forecast data for decision makers.
The U.S. Ophthalmic Sutures Market research report analysis from recent past with an eye on coming years in this report that also offers projections U.S. Ophthalmic Sutures Market targeted at helping in business decisions.
According to a new market report published by Persistence Market Research “Global Market Study on Ophthalmic Devices: Asia to Witness Highest Growth by 2020,” the global ophthalmic devices market was valued at USD 29,171.5 million in 2014 and is expected to grow at a CAGR of 6.5% from 2014 to 2020, to reach an estimated value of USD 42,685.1 million in 2020.
North America was the largest region in the ophthalmology drugs market in 2017, accounting for around 31% of the total market. Read Report https://www.thebusinessresearchcompany.com/report/ophthalmology-drugs-global-market-report-2018
The Business Research Company’s “Ophthalmology Drugs Global Market Report 2019” under its pharmaceutical drugs category covers market characteristics, key players, market size and trends from 2019 to 2022.
The implantable drug delivery devices market is expected to exceed more than US$ 27 billion by 2021; Growing at a CAGR of more than 8.6% in the given forecast period.
Eye Health Ingredients Market size was worth over USD 180 million in 2016 and is set to exceed 1.8 kilo tons by 2024. Get more details @ https://goo.gl/77ZuWB
According to Goldstein Research, “Rising digitization is resulting in constant technological advancement in ophthalmology and optometry which plays an important role in the growth of ophthalmic diagnostic equipment market across the globe. However, lack of ophthalmologists and dearth of trained medical staffs for eye related disorders are obstructing the adoption of ophthalmic diagnostic equipments in hospitals and clinics.”
Get more information about the market: https://www.imarcgroup.com/vision-care-market According to IMARC Group’s latest report, titled “Vision Care Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023”, the global vision care market reached a value of US$ 54 Billion in 2017. Request a sample report: https://www.imarcgroup.com/request?type=report&id=846&flag=B Browse more reports on Healthcare industry: http://www.imarcgroup.com/categories/healthcare-market-research-reports contact Us IMARC Group USA: +1-631-791-1145 Email: sales@imarcgroup.com Follow us on twitter: @imarcglobal
Global Market Estimates is a market research and business consulting company who has proven track record in serving Fortune 500 companies. Request for a sample copy of the Lutein Supplement Market report @: https://www.globalmarketestimates.com/lutein-supplement-market/
Global Market Estimates is a market research and business consulting company who has proven track record in serving Fortune 500 companies Request for a sample copy of the Lutein Vitamin Market report @: https://www.globalmarketestimates.com/lutein-vitamin-market/
Get more details @ http://bit.ly/2kifrTF Companies operating in ophthalmic viscosurgical devices market include Alcon, Abbott Medical Optics, Carl Zeiss Meditec, Bausch & Lomb, Rayner, CIMA Technology, Precision Lens, Hyaltech, Maxigen Biotech, etc. Medical device manufacturers that can introduce novel innovative equipment will have huge benefits in the developing regions.
The limitation of one or more eye functions or visual systems is referred to as vision impairment. This can range from mild vision impairment to total blindness.
iGATE Research has released a research report on “Global Retinal Surgery Devices Market (By Devices Segment, Application, Geography, Region and Company Profile) – Global Forecast to 2025” Click here to view the complete report: http://igateresearch.com/FullReportDetail.php?p=132 Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com